Infarct size of fibrocytes to increase risk of heart attack - Video

Published On 2022-02-04T18:47:07+05:30 | Updated On 4 Feb 2022 6:47 PM IST

Overview

According to a study in American Heart Journal Circulating fibrocytes measured 6 months after STEMI positively correlate with 6-month infarct size assessed by cardiac magnetic resonance imaging. Fibrocytes have been shown to home to the injured myocardium in patients with myocardial infarction, and the concentration of circulating fibrocytes is a serious risk factor that has to be considered.

Heart attack is classically is characterized by ST-segment elevation myocardial infarction (STEMI). It is one type of myocardial infarction in which a part of the heart muscle (myocardium) has died due to the obstruction of blood supply to the area. Infarct size is a strong predictor of outcomes after ST elevation myocardial infarction. Circulating fibrocytes are bone marrow-derived progenitor cells associated with fibrotic processes.

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751